Form 4: Accolade CEO Rajeev Singh Reports Stock Transactions

Sentiment:

SEC Filing


Accolade's CEO, Rajeev Singh, reports the conversion of Restricted Stock Units (RSUs) into common stock and a sale of shares to cover tax obligations.

Summary

  • Rajeev Singh, CEO of Accolade, Inc., filed a Form 4 detailing changes in beneficial ownership.
  • On July 10, 2024, 1,650 Restricted Stock Units (RSUs) were converted into common stock.
  • On July 11, 2024, Singh sold 649 shares of common stock at a price of $3.521 per share to cover tax withholding obligations.
  • Following these transactions, Singh directly owns 780,472 shares of common stock and indirectly owns 651,619 shares through Avanti Holdings, LLC.
  • The RSUs vest over three years from June 10, 2022, with one-third vesting on the first anniversary and the remainder vesting monthly thereafter.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing detailing stock transactions by the CEO. It doesn't inherently convey positive or negative sentiment.

Industry Context

Form 4 filings are standard practice for company insiders to report transactions in their company's stock, ensuring transparency and compliance with SEC regulations.

Stakeholder Impact

  • The sale of shares by the CEO could have a minor impact on shareholders, potentially creating slight downward pressure on the stock price in the short term.

Key Dates

DateDescription
June 10, 2022June 2022 RSU Vesting Commencement Date
July 10, 2024Conversion of Restricted Stock Units to Common Stock
July 11, 2024Sale of Common Stock to cover tax obligations
July 12, 2024Date of signature for the Form 4 filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.